Cyclerion Therapeutics (CYCN)

• Market cap: $6.29M
• 1 day: -3.14%
• 5 days: -8.18%
• 1 month: -18.48%
• 3 months: -27.99%
• 6 months: -14.83%
• Year to date: -24.92%
• 1 year: -17.94%
• 5 years: -95.37%
• 10 years: -99.15%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Employees: 1

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

20% more funds holding

Funds holding: 15 [Q3] → 18 (+3) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

24.38% less ownership

Funds ownership: 38.47% [Q3] → 14.09% (-24.38%) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

54% less capital invested

Capital invested by funds: $2.7M [Q3] → $1.23M (-$1.47M) [Q4]